AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis

NYSE:AMN • US0017441017

19.32 USD
+2.04 (+11.81%)
At close: Feb 20, 2026
19.1309 USD
-0.19 (-0.98%)
After Hours: 2/20/2026, 8:16:50 PM
Fundamental Rating

3

Overall AMN gets a fundamental rating of 3 out of 10. We evaluated AMN against 101 industry peers in the Health Care Providers & Services industry. The financial health of AMN is average, but there are quite some concerns on its profitability. AMN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year AMN was profitable.
  • In the past year AMN had a positive cash flow from operations.
  • In multiple years AMN reported negative net income over the last 5 years.
  • AMN had a positive operating cash flow in 4 of the past 5 years.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -12.88%, AMN is doing worse than 77.45% of the companies in the same industry.
  • With a Return On Equity value of -42.76%, AMN is not doing good in the industry: 71.57% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 2.08%, AMN perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.00%.
  • The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROIC 2.08%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • AMN's Operating Margin of 1.65% is in line compared to the rest of the industry. AMN outperforms 46.08% of its industry peers.
  • AMN's Operating Margin has declined in the last couple of years.
  • AMN has a Gross Margin (29.37%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of AMN has declined.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 29.37%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
  • There is no outstanding debt for AMN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.42 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AMN's Altman-Z score of 2.42 is in line compared to the rest of the industry. AMN outperforms 55.88% of its industry peers.
  • AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.80, AMN is in the better half of the industry, outperforming 71.57% of the companies in the same industry.
  • AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.31, AMN is not doing good in the industry: 65.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Altman-Z 2.42
ROIC/WACC0.27
WACC7.61%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.05, AMN is doing worse than 66.67% of the companies in the same industry.
  • AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
  • AMN has a worse Quick ratio (1.05) than 60.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

  • The earnings per share for AMN have decreased strongly by -58.91% in the last year.
  • AMN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.94% yearly.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 52.37% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 7.67% on average per year.
EPS Next Y-49.83%
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
EPS Next 5Y52.37%
Revenue Next Year-5.63%
Revenue Next 2Y-0.9%
Revenue Next 3Y8.06%
Revenue Next 5Y7.67%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.21 indicates a correct valuation of AMN.
  • Based on the Price/Earnings ratio, AMN is valued cheaper than 86.27% of the companies in the same industry.
  • AMN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 28.32, AMN can be considered very expensive at the moment.
  • AMN's Price/Forward Earnings ratio is in line with the industry average.
  • AMN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 14.21
Fwd PE 28.32
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 85.29% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
  • 99.02% of the companies in the same industry are more expensive than AMN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA 7.09
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AMN's earnings are expected to grow with 78.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.69%
EPS Next 3Y78.98%

0

5. Dividend

5.1 Amount

  • No dividends for AMN!.
Industry RankSector Rank
Dividend Yield 0%

AMN HEALTHCARE SERVICES INC

NYSE:AMN (2/20/2026, 8:16:50 PM)

After market: 19.1309 -0.19 (-0.98%)

19.32

+2.04 (+11.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners109.44%
Inst Owner Change-2.04%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap742.08M
Revenue(TTM)N/A
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.27 (10.09%)
Short Float %5.11%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)2.1%
PT rev (3m)1.39%
EPS NQ rev (1m)2.3%
EPS NQ rev (3m)24.26%
EPS NY rev (1m)2.26%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 14.21
Fwd PE 28.32
P/S 0.27
P/FCF 3.33
P/OCF 2.78
P/B 1.15
P/tB N/A
EV/EBITDA 7.09
EPS(TTM)1.36
EY7.04%
EPS(NY)0.68
Fwd EY3.53%
FCF(TTM)5.8
FCFY30.02%
OCF(TTM)6.94
OCFY35.94%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.66
Profitability
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROCE 2.81%
ROIC 2.08%
ROICexc 2.16%
ROICexgc 6.84%
OM 1.65%
PM (TTM) N/A
GM 29.37%
FCFM 8.2%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Debt/EBITDA 4.12
Cap/Depr 27.3%
Cap/Sales 1.62%
Interest Coverage 0.95
Cash Conversion 129.62%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.42
F-Score4
WACC7.61%
ROIC/WACC0.27
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y-49.83%
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
EPS Next 5Y52.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.84%
Revenue Next Year-5.63%
Revenue Next 2Y-0.9%
Revenue Next 3Y8.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.38%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%

AMN HEALTHCARE SERVICES INC / AMN FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 3 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 3 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -49.83% in the next year.